Small animal models with functional human lymphohematopoietic systems are highly valuable for the study of human immune function under physiological and pathological conditions. Over the last two ...

In the current study, REGEN-COV® treatment led to rapid viral clearance and clinical improvement in the immunodeficient patients with long-standing COVID-19. The findings of this study ...

5,720 neutralizing antibody titer of the son-in-law's plasma that was given to his immunodeficient COVID-19 mother-in-law. The researchers also analyzed plasma titers in 17 other patients besides ...

5,720 neutralizing antibody titer of the son-in-law's plasma that was given to his immunodeficient COVID-19 mother-in-law. The researchers also analyzed plasma titers in 17 other patients besides ...

One of the most notable advancements in this field is the severely immunodeficient NOG mouse, first introduced in 2006. The NOG mouse lacks functional T cells, B cells, and NK cells, exhibits ...

We have crossed the prolactin-humanized mouse line into the immunodeficient NSG strain for effective xenotransplantation studies. Fresh surgical specimens from breast cancer patients were directly ...

A team of researchers at the Medical College of Wisconsin and Children's Hospital of Wisconsin Research Institute defined a new treatment for a potentially fatal lung disease in patients with a ...

Gut microbiota may be the key factor explaining why certain individuals do not respond well to the pneumococcal vaccine-a bacterium that can cause various diseases, such as pneumonia. This ...

Infections by the yeast Candida albicans represent a significant public health problem and a common complication in immunodeficient individuals such as AIDS patients, cancer patients undergoing ...

NORTH BRUNSWICK, N.J., February 03, 2025--(BUSINESS WIRE)--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient ...

Immunodeficient and immunocompromised people may require an additional dose of COVID-19 vaccine, but India's current priority is to administer two doses to everybody in the country, said Dr NK ...